tert-butyl peroxybenzoate has been researched along with atropine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang-Andersen, B; Bundgaard, C; Christoffersen, CT; Hentzer, M; Larsen, K; Mikkelsen, GK; Plath, N; Sams, AG | 1 |
| Carrington, SJ; Cho, HP; Conn, PJ; Digby, GJ; Hopkins, CR; Le, U; Lindsley, CW; Lovell, KM; Niswender, CM; Sevel, C; Sheffler, DJ; Tarr, JC; Wood, MR | 1 |
2 other study(ies) available for tert-butyl peroxybenzoate and atropine
| Article | Year |
|---|---|
Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.
Topics: Allosteric Regulation; Animals; Benzeneacetamides; Benzoxazines; Brain; Calcium; Cell Line; Cricetinae; Cricetulus; Female; Hepatocytes; Humans; In Vitro Techniques; Male; Maze Learning; Memory, Short-Term; Mice; Nootropic Agents; Oxazines; Piperidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Structure-Activity Relationship | 2010 |
Further exploration of M₁ allosteric agonists: subtle structural changes abolish M₁ allosteric agonism and result in pan-mAChR orthosteric antagonism.
Topics: Acetylcholine; Allosteric Regulation; Allosteric Site; Animals; Benzamides; Benzimidazoles; Calcium; CHO Cells; Cricetinae; Cricetulus; Humans; Piperidines; Rats; Receptor, Muscarinic M1; Receptors, Muscarinic; Structure-Activity Relationship; Transfection | 2013 |